2019 ACR/ARP Annual Meeting

November 8-13, 2019. Atlanta, GA.

View by Number View by Title View Sessions

View by Date

Tuesday, November 12, 2019

2:30PM-4:00PM: Abstract Number: 2790

Platelet Mediates Neutrophil Extracellular Traps Formation via TLR Signaling in ANCA-associated Vasculitis

5T096: Vasculitis – ANCA-Associated II (2786–2791)

2:30PM-4:00PM: Abstract Number: 2794

Predictors of Incident and Worsening Lumbar Spine Degeneration: The Johnston County Osteoarthritis Project

5T101: Clinical Aspects & Outcomes Research (2792–2797)

2:30PM-4:00PM: Abstract Number: 2787

Predictors of Renal Involvement in ANCA-Associated Vasculitis

5T096: Vasculitis – ANCA-Associated II (2786–2791)

2:30PM-4:00PM: Abstract Number: 2775

Pregnancy Rates and Outcomes in Early Axial Spondyloarthritis: Analysis of the DESIR Cohort

5T094: Spondyloarthritis Including Psoriatic Arthritis – Clinical V: Axial Spondyloarthritis Clinical Studies (2774–2779)

2:30PM-4:00PM: Abstract Number: 2786

Renal Histopathological Classifications Predict the Renal Outcomes of Plasma Exchange-Treated ANCA-Associated Vasculitides with Renal Failure

5T096: Vasculitis – ANCA-Associated II (2786–2791)

2:30PM-4:00PM: Abstract Number: 2735

Response Gene to Complement -32 Exerts Proinflammatory and Profibrotic Effects in Immune Complex Gediated Glomerulonephritis

5T087: Edmond L. Dubois, MD Memorial Lecture: SLE – Basic Science (2733–2737)

2:30PM-4:00PM: Abstract Number: 2781

Risk of Cardiovascular Disease Associated with the Use of Glucocorticoids in Patients with Incident Systemic Lupus Erytematosus: A Population-based Study

5T093: SLE – Clinical V: Emerging Knowledge of Current Treatments (2780–2785)

2:30PM-4:00PM: Abstract Number: 2734

Signaling Lymphocytic Activation Molecule Family (SLAMF) Receptors Deregulation Is Implicated in the Altered Function of NK Cells in Systemic Lupus Erythematosus

5T087: Edmond L. Dubois, MD Memorial Lecture: SLE – Basic Science (2733–2737)

2:30PM-4:00PM: Abstract Number: 2739

Skin Disease Activity and Autoantibody Phenotype Are Major Determinants of Blood Interferon Signatures in Dermatomyositis

5T088: Genetics, Genomics & Proteomics (2738–2743)

2:30PM-4:00PM: Abstract Number: 2759

Stopping NSAIDs for Arthritis Pain (SNAP): A Randomized Withdrawal Trial Comparing NSAIDs to Cognitive Behavioral Therapy

5T090: Osteoarthritis – Clinical II: Novel Therapies (2756–2761)

2:30PM-4:00PM: Abstract Number: 2756

Subcutaneous Tanezumab versus NSAID for the Treatment of Osteoarthritis: Joint Safety Events in a Randomized, Double-Blind, Active-Controlled, 80-Week, Phase-3 Study

5T090: Osteoarthritis – Clinical II: Novel Therapies (2756–2761)

2:30PM-4:00PM: Abstract Number: 2752

Successfull Evaluation of a Predefined Set of Anatomic Sites in the Pelvis of Patients with Polymyalgia Rheumatica Showing Extracapsular Inflammation as Visualized by Contrast Enhanced Magnetic Resonance Imaging

5T089: Imaging of Rheumatic Diseases II (2750–2755)

2:30PM-4:00PM: Abstract Number: 2740

Takayasu Arteritis Associated Risk Locus in IL6 Represses the Anti-inflammatory Gene GPNMB Through Chromatin Looping and Recruiting MEF2-HDAC Complex

5T088: Genetics, Genomics & Proteomics (2738–2743)

2:30PM-4:00PM: Abstract Number: 2796

The Association Between Omega-3 Supplementation and Disease Activity in a Rheumatoid Arthritis (RA) Observational Cohort

5T101: Clinical Aspects & Outcomes Research (2792–2797)

2:30PM-4:00PM: Abstract Number: 2792

The Need for Personalized, Non-Pharmacological Intervention Programmes in Autoimmune Connective Tissue Disorders: Results of a EULAR-Funded Scoping Review with a Nested, Descriptive Meta-Analysis

5T101: Clinical Aspects & Outcomes Research (2792–2797)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].